SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 29 filers reported holding SIERRA ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $74,000 | -11.9% | 216,179 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $84,000 | -30.6% | 216,179 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $121,000 | -67.3% | 216,179 | 0.0% | 0.00% | -66.7% |
| Q1 2019 | $370,000 | +29.8% | 216,179 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $285,000 | -22.6% | 216,179 | 0.0% | 0.01% | -14.3% |
| Q3 2018 | $368,000 | -42.5% | 216,179 | 0.0% | 0.01% | -41.7% |
| Q2 2018 | $640,000 | +43.2% | 216,179 | 0.0% | 0.01% | +33.3% |
| Q1 2018 | $447,000 | -42.4% | 216,179 | +4.0% | 0.01% | -43.8% |
| Q4 2017 | $776,000 | +136.6% | 207,923 | -1.7% | 0.02% | +128.6% |
| Q3 2017 | $328,000 | +26.6% | 211,624 | -4.5% | 0.01% | +16.7% |
| Q2 2017 | $259,000 | -21.0% | 221,624 | +3.5% | 0.01% | -25.0% |
| Q1 2017 | $328,000 | – | 214,109 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $10,708,000 | 2.76% |
| New Leaf Venture Partners, L.L.C. | 5,020,446 | $6,627,000 | 1.82% |
| Prosight Management, LP | 2,553,943 | $3,371,000 | 1.74% |
| Abingworth LLP | 1,444,445 | $1,892,000 | 1.72% |
| Broadfin Capital, LLC | 4,880,327 | $6,442,000 | 0.85% |
| MANGROVE PARTNERS IM, LLC | 3,688,609 | $4,869,000 | 0.65% |
| Vivo Capital, LLC | 2,438,270 | $3,219,000 | 0.41% |
| PA Capital LLC | 138,752 | $183,000 | 0.19% |
| 683 Capital Management, LLC | 2,173,620 | $2,869,000 | 0.17% |
| ARMISTICE CAPITAL, LLC | 1,600,000 | $2,112,000 | 0.16% |